Evinacumab for treating homozygous familial hypercholesterolaemia in people 12 years and over

  • Technology appraisal guidance
  • TA1002
  • Published: 

History

Documents created during the development process.

Expected publication

Final draft guidance

Declaration of interests

Invitation to participate

Topic selection

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 2704

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators